| 분자 | Cat. No. | Product Name | 종 | Host | 구조 | 순도 | Activity | 규격 및 가격 |
|---|---|---|---|---|---|---|---|---|
| Fc gamma RIII / CD16 | HOT FC6-C52H9 | Cynomolgus Fc gamma RIII / CD16 Protein, His Tag (MALS & BLI verified) | Cynomolgus | HEK293 | ![]() | MALSSDS-PAGE | $225.00 50ug | |
| Fc gamma RIII / CD16 | HOTAvitag FC6-C82E0 | Biotinylated Cynomolgus Fc gamma RIII / CD16 Protein, His,Avitag™ (MALS & BLI verified) | Cynomolgus | HEK293 | ![]() | MALSSDS-PAGE | $380.00 25ug | |
| Fc gamma RIII / CD16 | HOT CDA-M52H8 | Mouse Fc gamma RIII / CD16 Protein, His Tag (SPR & MALS verified) | Mouse | HEK293 | ![]() | MALSSDS-PAGE | $225.00 50ug | |
| Fc gamma RIII / CD16 | Avitag FC6-M82E0 | Biotinylated Mouse Fc gamma RIII / CD16 Protein, His,Avitag™ (MALS & SPR verified) | Mouse | HEK293 | ![]() | MALSSDS-PAGE | $360.00 25ug | |
| Fc gamma RIII / CD16 | Rhesus macaque Fc gamma RIII / CD16 Protein, His Tag (SPR & MALS verified) | Rhesus macaque | HEK293 | ![]() | MALSSDS-PAGE | $225.00 50ug |
| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|
| Acimtamig | AFM-13 | Phase 2 Clinical | The University Of Texas MD Anderson Cancer Center | Hodgkin Disease; Lymphoma, B-Cell; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Mycosis Fungoides | 상세 |
| IPH-6501 | IPH-6501; IPH-65 | Phase 2 Clinical | Innate Pharma SA | Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasms | 상세 |
| FT-538 | FT-538 | Phase 2 Clinical | Fate Therapeutics Inc | Coronavirus Disease 2019 (COVID-19); Fallopian Tube Neoplasms; HIV Infections; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Respiratory Distress Syndrome, Adult; Solid tumours | 상세 |
| GMA-161 | GMA-161 | Phase 1 Clinical | Macrogenics Inc, Sanofi | Purpura, Thrombocytopenic, Idiopathic | 상세 |
| GTB-5550 | GTB-5550; B7H3 TriKE™; cam1615B7H3; GTB-5550 TriKE™ | Phase 1 Clinical | University Of Minnesota | Solid tumours | 상세 |
| FT-576 | FT-576 | Phase 1 Clinical | Fate Therapeutics Inc, University Of Minnesota | Bone Marrow Neoplasms; Multiple Myeloma | 상세 |
| AFM-28 | AFM-28 | Phase 1 Clinical | Affimed | Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Neoplasms | 상세 |
| Donor-derived CD123-CD16 bispecific antibody-modified NK cells therapy(Chinese PLA General Hospital) | Phase 1 Clinical | Pla General Hospital | Leukemia, Myeloid, Acute | 상세 | |
| GTB-3650 | GTB-3650; GTB-360; OXS-3350; OXS-C3550 | Phase 1 Clinical | Masonic Cancer Center, University Of Minnesota | Bone Marrow Neoplasms; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes | 상세 |
| BGB-B3227 | BGB-B3227 | Phase 1 Clinical | BeOne Medicines (Beijing) Co Ltd | Gastrointestinal Neoplasms; Lung Neoplasms; Neoplasm Metastasis; Neoplasms; Solid tumours | 상세 |
| SM-3321 | SM-3321; SM3321 | Phase 1 Clinical | Zhuhai StarMab BioMed Technology Ltd | Leukemia, Myeloid, Acute; Neoplasms | 상세 |
| FT-596 | FT-596 | Phase 1 Clinical | Fate Therapeutics Inc | Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin | 상세 |
| SAR-443579 | SAR-443579; SAR443579; SAR'579; IPH6101; IPH-6101 | Phase 1 Clinical | Sanofi | Blastic Plasmacytoid Dendritic Cell Neoplasm; Hematologic Diseases; Leukemia, B-Cell; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 상세 |
| FT-516 | FT-516 | Phase 1 Clinical | Fate Therapeutics Inc, University Of Minnesota | Abdominal Neoplasms; Coronavirus Disease 2019 (COVID-19); Fallopian Tube Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, B-Cell; Ovarian Neoplasms; Solid tumours | 상세 |